Yonsei University · Medicine
Jin Young Ahn 교수의 연구실은 감염성 질환의 조기 진단과 치료 전략 개발에 초점을 맞추고 있습니다. 특히 코로나19와 같은 신종 감염병에 대한 혈장 치료의 유효성과 메티실린내성 황색포도상구균 등 다제내성 세균에 의한 균혈증의 조기 진단 및 적절한 항생제 치료의 중요성을 연구하고 있습니다. 또한 중증 질환 환자의 기능적 회복을 높이기 위한 조기 재활 치료 전략 개발도 함께 진행 중입니다.
Figures are computed from collected data and may differ slightly.
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to sys
ESBL production is significantly associated with mortality in patients with bacteremia caused by P. mirabilis. Rapid detection of ESBL expression and prompt appropriate antimicrobial therapy are required to reduce mortality caused by P. mirabilis bacteremia.
Early physical rehabilitation may improve functional recovery at hospital discharge, especially in patients with high initial severity scores.
Open papers in the app to read, cite, and organize with AI.
